BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30778058)

  • 1. MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1.
    Yang Y; Ishak Gabra MB; Hanse EA; Lowman XH; Tran TQ; Li H; Milman N; Liu J; Reid MA; Locasale JW; Gil Z; Kong M
    Nat Commun; 2019 Feb; 10(1):809. PubMed ID: 30778058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycolysis and tumor progression promoted by the m
    Yang K; Zhong Z; Zou J; Liao JY; Chen S; Zhou S; Zhao Y; Li J; Yin D; Huang K; Li Y
    Cancer Lett; 2024 May; 590():216840. PubMed ID: 38604311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth.
    Wang VM; Ferreira RMM; Almagro J; Evan T; Legrave N; Zaw Thin M; Frith D; Carvalho J; Barry DJ; Snijders AP; Herbert E; Nye EL; MacRae JI; Behrens A
    Nat Cell Biol; 2019 Nov; 21(11):1425-1435. PubMed ID: 31685994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m
    Qing Y; Dong L; Gao L; Li C; Li Y; Han L; Prince E; Tan B; Deng X; Wetzel C; Shen C; Gao M; Chen Z; Li W; Zhang B; Braas D; Ten Hoeve J; Sanchez GJ; Chen H; Chan LN; Chen CW; Ann D; Jiang L; Müschen M; Marcucci G; Plas DR; Li Z; Su R; Chen J
    Mol Cell; 2021 Mar; 81(5):922-939.e9. PubMed ID: 33434505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism.
    Bott AJ; Shen J; Tonelli C; Zhan L; Sivaram N; Jiang YP; Yu X; Bhatt V; Chiles E; Zhong H; Maimouni S; Dai W; Velasquez S; Pan JA; Muthalagu N; Morton J; Anthony TG; Feng H; Lamers WH; Murphy DJ; Guo JY; Jin J; Crawford HC; Zhang L; White E; Lin RZ; Su X; Tuveson DA; Zong WX
    Cell Rep; 2019 Oct; 29(5):1287-1298.e6. PubMed ID: 31665640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis.
    Tu MJ; Duan Z; Liu Z; Zhang C; Bold RJ; Gonzalez FJ; Kim EJ; Yu AM
    Mol Pharmacol; 2020 Dec; 98(6):686-694. PubMed ID: 33051382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma.
    Recouvreux MV; Grenier SF; Zhang Y; Esparza E; Lambies G; Galapate CM; Maganti S; Duong-Polk K; Bhullar D; Naeem R; Scott DA; Lowy AM; Tiriac H; Commisso C
    Nat Cancer; 2024 Jan; 5(1):100-113. PubMed ID: 37814011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor.
    Wen S; Lin X; Luo W; Pan Y; Liao F; Wang Z; Zhan B; Feng J; Huang H
    BMC Cancer; 2024 Apr; 24(1):485. PubMed ID: 38632504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDIT3 Directs a Dual Mechanism to Balance Glycolysis and Oxidative Phosphorylation during Glutamine Deprivation.
    Li M; Thorne RF; Shi R; Zhang XD; Li J; Li J; Zhang Q; Wu M; Liu L
    Adv Sci (Weinh); 2021 Jun; 8(11):e2003732. PubMed ID: 34105294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of lipophagy impairment for anticancer effects of glycolysis-suppressed pancreatic ductal adenocarcinoma cells.
    Zhang Z; Aoki H; Umezawa K; Kranrod J; Miyazaki N; Oshima T; Hirao T; Miura Y; Seubert J; Ito K; Aoki S
    Cell Death Discov; 2024 Apr; 10(1):166. PubMed ID: 38580661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake.
    Lowman XH; Hanse EA; Yang Y; Ishak Gabra MB; Tran TQ; Li H; Kong M
    Cell Rep; 2019 Mar; 26(11):3051-3060.e4. PubMed ID: 30865893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p66ShcA promotes malignant breast cancer phenotypes by alleviating energetic and oxidative stress.
    Lewis K; La Selva R; Maldonado E; Annis MG; Najyb O; Cepeda Cañedo E; Totten S; Hébert S; Sabourin V; Mirabelli C; Ciccolini E; Lehuédé C; Choinière L; Russo M; Avizonis D; Park M; St-Pierre J; Kleinman CL; Siegel PM; Ursini-Siegel J
    Redox Biol; 2024 Apr; 70():103028. PubMed ID: 38211442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enhancement of glycolysis regulates pancreatic cancer metastasis.
    Yang J; Ren B; Yang G; Wang H; Chen G; You L; Zhang T; Zhao Y
    Cell Mol Life Sci; 2020 Jan; 77(2):305-321. PubMed ID: 31432232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer.
    Karasinska JM; Topham JT; Kalloger SE; Jang GH; Denroche RE; Culibrk L; Williamson LM; Wong HL; Lee MKC; O'Kane GM; Moore RA; Mungall AJ; Moore MJ; Warren C; Metcalfe A; Notta F; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Renouf DJ; Schaeffer DF
    Clin Cancer Res; 2020 Jan; 26(1):135-146. PubMed ID: 31481506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1α/PFKFB3/PFK1 pathway.
    Hu L; Zeng Z; Xia Q; Liu Z; Feng X; Chen J; Huang M; Chen L; Fang Z; Liu Q; Zeng H; Zhou X; Liu J
    Life Sci; 2019 Dec; 239():116966. PubMed ID: 31626790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.
    Lang L; Chemmalakuzhy R; Shay C; Teng Y
    Adv Exp Med Biol; 2019; 1134():243-258. PubMed ID: 30919341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PFKP is highly expressed in lung cancer and regulates glucose metabolism.
    Shen J; Jin Z; Lv H; Jin K; Jonas K; Zhu C; Chen B
    Cell Oncol (Dordr); 2020 Aug; 43(4):617-629. PubMed ID: 32219704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
    Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming.
    Liu J; Liu ZX; Wu QN; Lu YX; Wong CW; Miao L; Wang Y; Wang Z; Jin Y; He MM; Ren C; Wang DS; Chen DL; Pu HY; Feng L; Li B; Xie D; Zeng MS; Huang P; Lin A; Lin D; Xu RH; Ju HQ
    Nat Commun; 2020 Mar; 11(1):1507. PubMed ID: 32198345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphofructokinase 1 Platelet Isoform Promotes β-Catenin Transactivation for Tumor Development.
    Lee JH; Shao F; Ling J; Lu S; Liu R; Du L; Chung JW; Koh SS; Leem SH; Shao J; Xing D; An Z; Lu Z
    Front Oncol; 2020; 10():211. PubMed ID: 32195176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.